Group 1 - The company, Guichuang Tongqiao (02190), announced a share buyback on September 24, 2025, spending HKD 1.1984 million to repurchase 50,000 shares [1] - The repurchase price per share ranged from HKD 23.66 to HKD 25.06 [1]

Core Viewpoint - The company, Guichuang Tongqiao (02190.HK), announced a share buyback on September 24, 2023, spending HKD 1.2 million to repurchase 50,000 shares [1]. Summary by Category - **Company Actions** - The company executed a buyback of 50,000 shares at a cost of HKD 1.2 million on September 24, 2023 [1].

Core Viewpoint - The company, Zhichuang Tongqiao (02190), announced a share buyback plan, indicating confidence in its stock value and future prospects [1] Group 1: Share Buyback Details - The company will repurchase 50,000 shares at a total cost of HKD 1,198,400 [1] - The buyback price per share ranges from HKD 23.66 to HKD 25.06 [1] - The buyback is scheduled for September 24, 2025 [1]

FF305 翌日披露報表 (股份發行人 ── 已發行股份或庫存股份變動、股份購回及/或在場内出售庫存股份) 表格類別： 股票 狀態： 新提交 公司名稱： 歸創通橋醫療科技股份有限公司 呈交日期： 2025年9月24日 如上市發行人的已發行股份或庫存股份出現變動而須根據《香港聯合交易所有限公司（「香港聯交所」）證券上市規則》(「《主板上市規則》」)第13.25A條 / 《香港聯合交易所有限公司GEM證券 上市規則》(「《GEM上市規則》」)第17.27A條作出披露，必須填妥第一章節 。 | 第一章節 | | | | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 1. 股份分類 | 普通股 | 股份類別 | H | | 於香港聯交所上市 | 是 | | | 證券代號 (如上市) | 02190 | 說明 | H股 | | | | | | A. 已發行股份或庫存股份變動 | | | | | | | | | | | | 已發行股份（不包括庫存股份）變動 | | 庫存股份變動 | | | | | 事件 | 已發行股份（不包括庫存股份）數 目 | ...

Summary of Key Points Core Viewpoint - Multiple companies, including Tencent Holdings and Anta Sports, conducted share buybacks on September 23, 2025, with Tencent leading in terms of buyback amount and quantity [1][2]. Group 1: Buyback Details - Tencent Holdings (00700) repurchased 867,000 shares for a total of 550 million [2]. - Anta Sports (02020) repurchased 2.12 million shares for a total of 200 million [2]. - Hang Seng Bank (00011) repurchased 200,000 shares for a total of 23.57 million [2]. - China Petroleum & Chemical Corporation (00386) repurchased 5.51 million shares for a total of 22.44 million [2]. - Stone Four Pharmaceutical Group (02005) repurchased 5 million shares for a total of 14.67 million [2]. Group 2: Cumulative Buyback Data - Tencent's cumulative buyback for the year reached 61.59 million shares, accounting for 0.670% of its total share capital [2]. - Anta Sports' cumulative buyback for the year reached 4.24 million shares, accounting for 0.151% of its total share capital [2]. - China Hongqiao Group (01378) had a cumulative buyback of 15.2 million shares, accounting for 1.620% of its total share capital [2]. - Coolpad Group (02369) had a significant cumulative buyback of 27.25 million shares, accounting for 6.653% of its total share capital [2].

Group 1 - Yunfeng Financial Holdings (00376) reported an increase in shareholding from 1.636 billion shares to 1.828 billion shares, raising its holding percentage from 42.30% to 45.02% [2] - Wan Ke Yi Lian (01762) maintained its shareholding at 420 million shares, with a slight increase in holding percentage from 23.73% to 23.74% [2] - Stone Four Pharmaceutical Group (02005) increased its shareholding from 1.198 billion shares to 1.203 billion shares, with a rise in holding percentage from 40.58% to 40.75% [2] Group 2 - Guichuang Tongqiao-B (02190) saw a decrease in shareholding from 19.3872 million shares to 15.8872 million shares, with a decline in holding percentage from 6.01% to 4.93% [2] - Multiple entities, including Key Imagination Limited and Yunfeng Financial Holdings Limited, reported the same increase in shareholding for Yunfeng Financial Holdings [2] - The changes in shareholding may be influenced by corporate actions such as rights issues, consolidations, or splits [2]

Core Viewpoint - The company, Guichuang Tongqiao (02190.HK), has been actively repurchasing its shares, indicating a potential strategy to enhance shareholder value and confidence in its stock performance [1] Summary by Relevant Sections Share Buyback Activity - On September 23, the company spent HKD 1.214 million to repurchase 50,000 shares [1] - On September 22, the company spent HKD 1.245 million to repurchase another 50,000 shares [1]

FF305 翌日披露報表 (股份發行人 ── 已發行股份或庫存股份變動、股份購回及/或在場内出售庫存股份) 表格類別： 股票 狀態： 新提交 公司名稱： 歸創通橋醫療科技股份有限公司 如上市發行人的已發行股份或庫存股份出現變動而須根據《香港聯合交易所有限公司（「香港聯交所」）證券上市規則》(「《主板上市規則》」)第13.25A條 / 《香港聯合交易所有限公司GEM證券 上市規則》(「《GEM上市規則》」)第17.27A條作出披露，必須填妥第一章節 。 | 第一章節 | | | | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 1. 股份分類 | 普通股 | 股份類別 | H | | 於香港聯交所上市 | 是 | | | 證券代號 (如上市) | 02190 | 說明 | H股 | | | | | | A. 已發行股份或庫存股份變動 | | | | | | | | | | | 已發行股份（不包括庫存股份）變動 | | | 庫存股份變動 | | | | | 事件 | 已發行股份（不包括庫存股份）數 目 | | 佔有關事件前的現有已發 行股份 ...

中期報 告 202 5 Interim Report 202 5 Interim Report 2025 中期報告 目錄 | 公司資料 | 2 | | --- | --- | | 財務及業務摘要 | 4 | | 管理層討論及分析 | 5 | | 企業管治及其他資料 | 32 | | 中期財務資料的審閱報告 | 47 | | 中期簡明綜合全面收益表 | 48 | | 中期簡明綜合資產負債表 | 49 | | 中期簡明綜合權益變動表 | 51 | | 中期簡明綜合現金流量表 | 52 | | 中期簡明綜合財務資料附註 | 53 | | 釋義 | 87 | 頁數 公司資料 董事會 於最後實際可行日期，董事會成員如下： 執行董事 趙中博士 （董事長） 謝陽先生 李崢博士 非執行董事 李東方先生 王大松博士 獨立非執行董事 計劍博士 邱妘女士 錢湘博士 聯席公司秘書 袁泉衛先生 關秀妍女士 授權代表 趙中博士 關秀妍女士 監事 馬長安先生 （主席） 劉濤先生 王宏波女士 審計委員會 邱妘女士 （主席） 計劍博士 錢湘博士 薪酬委員會 計劍博士 （主席） 李東方先生 錢湘博士 提名委員會 趙中博士 （主席） 邱妘女士 計 ...

格隆汇9月22日丨归创通桥(02190.HK)公告，9月22日耗资124.5万港元回购5万股。 ...